All articles

Management of Microbiological Contamination: Identifying, Understanding and Preventing Recurrence

Published on 07/05/26 in the following categories Antimicrobials

Microbiological contamination is not limited to a non-compliant result. In R&D development, quality control, an industrial process or biological production, it immediately raises concrete questions: where does the contaminant come from, is it isolated or recurrent, what is its impact, and how can its reappearance be prevented?

The response is not simply to identify the bacterium and then restart the process. To achieve lasting control of bacterial contamination, the investigation must be able to connect laboratory observations with the real operational context: samples, flows, raw materials, equipment, cleaning, disinfection and field practices.

At Smaltis, we approach these situations as a structured microbiological investigation: understanding the problem, isolating the contaminants, identifying and comparing the isolates, preserving useful material, and then testing appropriate prevention solutions.

Understanding the Context Before Selecting Analyses
Not all contamination events require the same level of investigation. An isolated alert during an exploratory phase, repeated contamination in quality control, or an incident affecting a critical process do not call for the same decisions.
The first step is therefore to gather the relevant information: sample type, history of incidents, culture conditions, sampling points, handling steps, cleaning and disinfection plan, and how results evolve from batch to batch. These elements make it possible to choose a proportionate strategy and avoid two pitfalls: under-investigating a contamination event that may recur, or multiplying analyses without a clear question.
A robust approach must remain decision-oriented: what needs to be understood in order to act effectively? This question guides the choice of analyses and the depth of the investigation.

Isolating Morphotypes: The Foundation of Reliable Interpretation

 

When a contaminated sample is received, it may contain several microbial populations. Colonies observed on agar plates may show different morphotypes, sometimes with very similar visual appearances. Before any identification step, it is therefore essential to observe, distinguish and re-isolate the colonies of interest.
This step makes it possible to obtain pure cultures that can be used for subsequent analyses. It directly determines the reliability of bacterial identification, comparisons between isolates, and resistance testing against cleaning or disinfection products.

 

At Smaltis, this step draws on extensive experience in microbial culture. Our teams routinely handle both fastidious and non-fastidious species under a wide range of culture conditions. This expertise enables precise reading of agar plates, identification of relevant morphotypes and secure re-isolation steps. In microbiological contamination, the quality of interpretation often begins here: on the plate, even before the choice of identification technology.

Identifying and Comparing Contaminants
Once isolates have been obtained, the first challenge is to determine what organism is involved. Depending on the context, Smaltis can deploy several bacterial identification approaches: MALDI-TOF mass spectrometry, amplification and sequencing of the gene encoding 16S ribosomal RNA, or whole-genome sequencing when the expected level of resolution justifies it.
Identification gives the contaminant a name. In many situations, however, that name is not enough. When contamination recurs, affects several points in the process, or reappears after a corrective action, isolates must be compared with one another to determine whether they are related.
When whole genomes are available, genomic comparison can finely assess the relatedness between isolates and investigate a genetic link compatible with a common source or persistence within the process. In the absence of whole-genome sequencing data, approaches such as PFGE, or pulsed-field gel electrophoresis, can provide useful insight into clonality.
This comparison often changes the decision-making process. Two isolates belonging to the same species do not necessarily come from the same source. Conversely, very closely related isolates may reveal recurrent contamination linked to an environment, a piece of equipment, a raw material or a handling step. The objective is therefore to move from a simple microbiological finding to an actionable hypothesis regarding the origin of the contamination.

Preserving Isolates to Document the History

 

In microbiological contamination management, isolates are not merely samples to be analysed once. They can become a microbiological memory of the process.
Cryopreservation allows isolated strains to be stored for additional analyses, comparison of a new episode with a previous incident, or verification of the effectiveness of a preventive action. It provides continuity in situations where contamination events are intermittent, partial or difficult to connect with one another.

 

Smaltis offers storage solutions to secure these isolates over time. The aim is also to make the most of stored samples: keeping them available for new comparisons, enriching the history of a process, documenting recurrence or demonstrating that a corrective action has changed the situation. This traceability helps answer a key question: is this a new contaminant, or the return of a population already observed?

Testing Cleaning, Disinfection and Prevention Solutions

 

Identifying a contaminant is not enough. It is also necessary to understand how it responds to the solutions intended to control it. A cleaning or disinfection product may be effective in a theoretical setting, but less effective under real conditions of use: concentration, contact time, surface, matrix, organic load, biofilm or the sequence of process steps.

 

Smaltis can study the resistance of isolates to cleaning and disinfection products, compare several solutions and help interpret the results in light of field constraints.
The objective is to build a realistic prevention plan: which steps should be secured, which controls should be reinforced, which practices should be adapted, and how can it be verified that the risk of recurrence is truly decreasing?

The Smaltis Approach: From Incident to Prevention

Contamination is often experienced as an incident that must be corrected quickly. When properly investigated, however, it also becomes a source of information about the process. It may reveal a weakness in flows, an insufficiently protected step, a limitation in the cleaning plan or microbial persistence that had previously gone unnoticed.

The Smaltis approach consists in structuring this investigation without making it unnecessarily burdensome: starting from the context, isolating morphotypes, identifying contaminants, comparing isolates when necessary, preserving useful strains, and then testing appropriate cleaning, disinfection and prevention solutions.

This approach combines classical microbiology, molecular tools, culture expertise, clonality analysis, storage capability and an understanding of operational constraints. It makes it possible to move from a contamination finding to a documented control strategy that can be used directly by field, quality or R&D teams.

Need targeted support to identify the origin of a contamination event, compare isolates, test decontamination solutions or build a prevention plan? Contact our teams!

News and articles

Management of Microbiological Contamination: Identifying, Understanding and Preventing Recurrence

Microbiological contamination is not limited to a non-compliant result. In R&D development, quality control, an industrial process or biological production, it immediately raises concrete questions: where does the contaminant come from, is it isolated or recurrent, what is its impact, and how can its reappearance be prevented?

The response is not simply to identify the bacterium and then restart the process. To achieve lasting control of bacterial contamination, the investigation must be able to connect laboratory observations with the real operational context: samples, flows, raw materials, equipment, cleaning, disinfection and field practices.

At Smaltis, we approach these situations as a structured microbiological investigation: understanding the problem, isolating the contaminants, identifying and comparing the isolates, preserving useful material, and then testing appropriate prevention solutions.

READ THE POST

Skin Microbiome: Cultivating Rigor to Objectify Innovation

The skin microbiome is not mere scenery. It is a functional component of the skin, involved in protection against pathogens, immune dialogue, and the modulation of inflammation. It is a dynamic ecosystem shaped by subtle interactions between bacteria, yeasts, the host, and the environment.

Our approach is grounded in a simple conviction: understanding a microbiome is not merely about identifying it. It is about knowing how to culture it, interrogate it, and generate scientifically defensible data.

This is precisely how we approach the skin microbiome: as a complex ecosystem whose actors, dynamics, and mechanisms must be mastered before attempting to modulate its balance.

READ THE POST

The Story of a Microbiota That Became a Medicine

Once upon a time, in the hospitals of the twenty-first century, there was an infection that even antibiotics could no longer silence. An opportunistic infection caused by a bacterium called Clostridioides difficile, it often appeared in patients who were already vulnerable… and, above all, already heavily treated. Let us look back at the history of this infection, which gave rise to new therapeutic approaches.

READ THE POST

Probiotic Characterization: Demonstrating Safety and Substantiating Activity

Probiotics are often presented as a simple category. In reality, their characterization has become a demanding scientific and regulatory exercise. It is no longer enough to identify a species or to invoke a favorable history of use: the demonstration must now be conducted at the strain level, in a way that is consistent with the intended use, the target population, and the applicable regulatory framework. In the main reference frameworks, a microorganism can be qualified as a probiotic in the strict sense only if it is sufficiently characterized, safe for its intended use, alive at a relevant dose until the end of the product’s shelf life, and associated with a documented health benefit. [1,5,7,8]

The key question therefore becomes: what can we robustly demonstrate about its identity, safety, and functional activity? This is particularly true for new or poorly documented strains, for which taxonomy alone is not sufficient. The EFSA, GRAS, and Canadian frameworks converge on one central point: useful characterization is strain-level characterization interpreted in light of the final use. [1-6]

READ THE POST

Designing Bacterial Mutants: From Gene Editing to Robust Strain Engineering

The construction of bacterial mutants is a cornerstone of microbiology. Historically used to decipher gene function, it now plays an equally strategic role in bioproduction, biotechnology, and the development of therapeutic bacteria, where the engineered strain itself may ultimately become the final product.

This shift has profoundly changed how mutagenesis projects are approached. Today, the objective is no longer simply to modify a gene, but to design a strain aligned with its final application, operational constraints, and regulatory expectations.

READ THE POST

Lugdunin: the secret weapon of an indomitable bacterium

Once upon a time, an invisible battle was raging deep inside our noses. A microscopic battlefield, where bacteria fought relentlessly to defend their territory. Picture a small village of indomitable Gauls, surrounded on all sides… but instead of Romans, it’s microbes. And in this surprisingly strategic setting, a most unexpected antibiotic was discovered: lugdunin.

READ THE POST

2026: Taking on New Scientific Challenges Together

As we step into 2026, the entire Smaltis team sends you our warmest wishes. May this new year bring clarity, creativity, meaningful collaborations — and a few scientific breakthroughs that get the attention they deserve.

READ THE POST

Antimicrobial activity testing: measuring, understanding, and anticipating resistance

Every day, antimicrobials face their natural adversaries: bacteria.
But in this silent war, nothing remains static — bacteria learn, adapt, defend themselves… and develop increasingly sophisticated resistance mechanisms.
Smaltis is a microbiology CRO specialized in the study of antimicrobial resistance and the preclinical development of antimicrobials.
We support the developers of new antibiotics, peptides, biocides, and other anti-infective agents with a comprehensive panel of in vitro assays designed to meet the most demanding R&D challenges.

READ THE POST

Meeting the Innovation

Smaltis at the Key Industry Events of Autumn 2025! From medical devices to biotherapies, from fundamental research to industrial production, we meet project leaders to better understand microbiology needs and build new collaborations.

READ THE POST

New Offer Structure: 2 Business Units Supporting Your Projects

At Smaltis, our ambition remains unchanged: bringing microbiological excellence to your innovations.
To better address the diversity of your needs, we have structured our offer around 2 complementary Business Units, true pillars of our scientific and technical commitment.

READ THE POST

Let's study your project!

Are you interested in our services? Ask our experts to study your needs and design a tailor-made collaboration with you.

Book a discovery call